Deutetrabenazine for Treatment of Chorea in Huntington Disease

被引：11

作者：

Geschwind, Michael D. ^{[1
]}

机构：

[1] Univ Calif San Francisco, 675 Nelson Rising Lane,Ste 190, San Francisco, CA 94158 USA

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2016年 / 316卷 / 01期

关键词：

D O I：

10.1001/jama.2016.8011

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：33 / 35

页数：3

共 11 条

[1]

Allen I. Elaine, 2007, QUAL PROG, P52

[2]

[Anonymous], 2010, Guidance for industry: pharmacokinetics in patients with impaired renal function - study design, data analysis, and impact on dosing and labeling, P1

[3]

Frank S, 2016, JAMA-J AM MED ASSOC, V316, P40, DOI [10.1001/jama.2016.8655, DOI 10.1001/JAMA.2016.8655]

[4] Using Deuterium in Drug Discovery: Leaving the Label in the Drug [J].

Gant, Thomas G. .

JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (09) :3595-3611

[5]

Huntington Study Group, 2016, 1 HD ARC HD

[6] Unified Huntington's disease rating scale: Reliability and consistency [J].

Kieburtz, K ;

Penney, JB ;

Como, P ;

Ranen, N ;

Shoulson, I ;

Feigin, A ;

Abwender, D ;

Greenamyre, JT ;

Higgins, D ;

Marshall, FJ ;

Goldstein, J ;

Steinberg, K ;

Shih, C ;

Richard, I ;

Hickey, C ;

Zimmerman, C ;

Orme, C ;

Claude, K ;

Oakes, D ;

Sax, DS ;

Kim, A ;

Hersch, S ;

Jones, R ;

Auchus, A ;

Olsen, D ;

BisseyBlack, C ;

Rubin, A ;

Schwartz, R ;

Dubinsky, R ;

Mallonee, W ;

Gray, C ;

Godfrey, N ;

Suter, G ;

Shannon, KM ;

Stebbins, GT ;

Jaglin, JA ;

Marder, K ;

Taylor, S ;

Louis, E ;

Moskowitz, C ;

Thorne, D ;

Zubin, N ;

Wexler, N ;

Swenson, MR ;

Paulsen, J ;

Swerdlow, N ;

Albin, R ;

Wernette, C ;

Walker, F ;

Hunt, V .

MOVEMENT DISORDERS, 1996, 11 (02) :136-142

[7] Tetrabenazine as antichorea therapy in Huntington disease - A randomized controlled trial [J].

Marshall, FJ ;

Walker, F ;

Frank, S ;

Oakes, D ;

Plumb, S ;

Factor, SA ;

Fahn, S ;

Hunt, VP ;

Jankovic, J ;

Shinaman, A ;

Shoulson, I ;

Goldstein, J ;

Corey-Bloom, J ;

Belden, J ;

Wojcieszek, J ;

Nickerson, C ;

Higgins, D ;

McCall, M ;

Sanchez-Ramos, J ;

Stepanov, N ;

Kostyk, S ;

Harrison, J ;

Testa, C ;

Shannon, B ;

Feigin, A ;

Radtke, D ;

Nance, M ;

Stanton, P ;

Ashizawa, T ;

Hunter, C ;

Ondo, W ;

Rose, K ;

Geschwind, M ;

Jaglin, J ;

Shannon, K ;

Matthews, M ;

Colcher, A ;

Riendl, P ;

Blindauer, K ;

Dustin, K ;

Anderson, K ;

Fowler, S ;

Mehta, D ;

Hanna, P ;

Lindsay, P ;

Eberly, S ;

Zhao, HW ;

MacDonald, M ;

Young, A .

NEUROLOGY, 2006, 66 (03) :366-372

[8] Reporting of Noninferiority and Equivalence Randomized Trials Extension of the CONSORT 2010 Statement [J].

Piaggio, Gilda ;

Elbourne, Diana R. ;

Pocock, Stuart J. ;

Evans, Stephen J. W. ;

Altman, Douglas G. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (24) :2594-2604

[9] Huntington's disease: a clinical review [J].

Roos, Raymund A. C. .

ORPHANET JOURNAL OF RARE DISEASES, 2010, 5

[10] Through the looking glass: understanding non-inferiority [J].

Schumi, Jennifer ;

Wittes, Janet T. .

TRIALS, 2011, 12

← 1 2 →